Clinical significance of tumor necrosis and viability in non-small cell lung cancer

被引:8
|
作者
Moon, Seok Whan [1 ]
Kim, Jae Jun [2 ]
Jeong, Seong Cheol [2 ]
Kim, Yong Hwan [2 ]
Han, Jung Wook [2 ]
机构
[1] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
[2] Catholic Univ Korea, Coll Med, Uijeongbu St Marys Hosp, Dept Thorac & Cardiovasc Surg, Uijongbu 480717, South Korea
关键词
Lung cancer; tumor necrosis (TN); tumor viability (TV); prognosis; INTERNATIONAL-ASSOCIATION; CLASSIFICATION; SUBTYPE;
D O I
10.21037/jtd-21-1597
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: We included tumor necrosis (TN) and tumor viability (TV) in our prognostic assessment of patients with non-small cell lung cancer (NSCLC) and investigated their clinical significance. Methods: Medical records of all consecutive subjects who underwent a lobectomy with standard mediastinal lymph node dissection for NSCLC between 2015 to 2016, were reviewed retrospectively. We analyzed the associations of TN and TV with various parameters associated with prognosis as well as survival in NSCLC patients. All analyses were performed regarding neoadjuvant therapy status [the group without neoadjuvant therapy (WON) vs. the group with neoadjuvant therapy (WN)]. Results: A consecutive 154 patients (mean age: 65.0 +/- 10.1 years) were included into the present study. Fifteen patients underwent neoadjuvant therapy. Final pathologic stages were IA1 (n=13), IA2 (n=30), IA3 (n=32), IB (n=40), IIA (n=9), IIB (n=18), and IIIA (n=12). WN significantly showed higher TN (P=0.005) and lower TV (P<0.001) than WON. Tumors with vascular, lymphatic, and perineural invasion showed significantly lower TV and higher TN than cases without these features (P=0.014, P=0.019, and P=0.012 for TV; P=0.001, P<0.001, and P<0.001 for TN, respectively). Tumors with poorer differentiation had lower TV (P<0.001) and higher TN (P<0.001) than more differentiated tumors. There was a positive correlation between TN and tumor size (P<0.001) and a negative correlation between TV and tumor size (P=0.031). TN significantly increased as pathologic stage increased (P=0.001), and TV significantly decreased as pathologic stage increased (P=0.038). The group without TN survived significantly longer than the group with TN (P=0.016) in N0 disease and presence of TN and pT stage were independent prognostic factors for survival in N0 disease (P=0.037 and P=0.021, respectively). There was a positive correlation between TN and Ki-67 level (P=0.027). In WN, TN was significantly associated with differentiation (P=0.035), tumor size (P=0.008), and pT stage (P=0.031) but not overall pathologic stage or survival. Conclusions: Presence of histological TN was associated with prognosis of NSCLC, especially in N0 disease, and its usage as a diagnostic or prognostic tool and determination of resection extent could potentially provide prognostic information that can facilitate better management of NSCLC.
引用
收藏
页码:892 / 904
页数:13
相关论文
共 50 条
  • [21] Objective Measurement and Clinical Significance of TILs in Non-Small Cell Lung Cancer
    Schalper, Kurt A.
    Brown, Jason
    Carvajal-Hausdorf, Daniel
    McLaughlin, Joseph
    Velcheti, Vamsidhar
    Syrigos, Konstantinos N.
    Herbst, Roy S.
    Rimm, David L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (03):
  • [22] Expression of angiopoietins and its clinical significance in non-small cell lung cancer
    Tanaka, F
    Ishikawa, S
    Yanagihara, K
    Miyahara, R
    Kawano, Y
    Li, M
    Otake, Y
    Wada, H
    CANCER RESEARCH, 2002, 62 (23) : 7124 - 7129
  • [23] The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients
    Kadota, Kyuichi
    Huang, Cheng-long
    Liu, Dage
    Ueno, Masaki
    Kushida, Yoshio
    Haba, Reiji
    Yokomise, Hiroyasu
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (07) : 1057 - 1067
  • [25] Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer
    Hirai, K
    Koizumi, K
    Haraguchi, S
    Hirata, T
    Mikami, I
    Fukushima, M
    Yamagishi, S
    Kawashima, T
    Okada, D
    Shimizu, K
    Kawamoto, M
    ANNALS OF THORACIC SURGERY, 2005, 79 (01): : 248 - 253
  • [26] The progress of tumor vaccines clinical trials in non-small cell lung cancer
    Wang, Xiaomu
    Niu, Yunping
    Bian, Fang
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025, 27 (03): : 1062 - 1074
  • [27] Tumor regression in non-small cell lung cancer
    Junker, K
    Klinke, V
    Bosse, U
    Thomas, M
    Muller, KM
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 113 - 117
  • [28] Tumor angiogenesis of non-small cell lung cancer
    Shijubo, N
    Kojima, H
    Nagata, M
    Ohchi, T
    Suzuki, A
    Abe, S
    Sato, N
    MICROSCOPY RESEARCH AND TECHNIQUE, 2003, 60 (02) : 186 - 198
  • [29] The clinical utility of tumor mutational burden in non-small cell lung cancer
    Greillier, Laurent
    Tomasini, Pascale
    Barlesi, Fabrice
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (06) : 639 - 646
  • [30] Clinical applications of circulating tumor cells in non-small cell lung cancer
    Gupta, Varun
    Noh, Ka-Won
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 135 - 135